Regulatory network analysis of LINC00472, a long noncoding RNA downregulated by DNA hypermethylation in colorectal cancer

Clinical Genetics
L ChenQi Liao

Abstract

Colorectal cancer (CRC), one of the common malignant cancers in the world, is caused by accumulated alterations of genetic and epigenetic factors over a long period of time. Along with that protein-coding genes being identified as oncogenes or tumor suppressors in CRC, a number of lncRNAs have also been found to be associated with CRC. Considering the important regulatory role of lncRNAs, the first goal of this study was to identify CRC-associated lncRNAs from a public database. One such lncRNA, LINC00472, was verified to be downregulated in CRC cell lines and cancer tissues compared with adjacent tissues. In addition, the down-regulation of LINC00472 seemed to be caused by DNA hypermethylation at its promoter region. Furthermore, the expression of LINC00472 and DNA methylation of promoter were significantly correlated with clinicopathological features. And DNA hypermethylation of LINC00472 may serve as a better diagnostic biomarker than its expression for CRC. Finally, we predicted the functions of LINC00472 and constructed a regulatory network and found LINC00472 may be involved in cell cycle and cell proliferation processes. Our results may provide a clue to further research into the function and regulatory mechanism of LINC...Continue Reading

References

Nov 14, 2006·Nucleic Acids Research·Tanya BarrettRon Edgar
Nov 8, 2008·Nucleic Acids Research·T S Keshava PrasadAkhilesh Pandey
Feb 26, 2009·Cell·Chris P PontingWolf Reik
Nov 11, 2010·Methods in Molecular Biology·Michael KohlBettina Warscheid
Jan 5, 2011·Cancer Research·Miao-Chih TsaiHoward Y Chang
May 12, 2011·Pathology Research International·Karen CurtinWade S Samowitz
Aug 17, 2011·Nucleic Acids Research·Qi LiaoYi Zhao
Mar 28, 2012·Epigenomics·Muriel X G DrahtKim M Smits
Oct 20, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Femke SimmerHendrik G Stunnenberg
Jan 30, 2013·Fertility and Sterility·Michal Inbar-FeigenbergRosanna Weksberg
Jan 30, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Man-Tang QiuLin Xu
May 18, 2013·Journal of Translational Medicine·Peng QiXiang Du
Jun 4, 2013·Journal of Hematology & Oncology·Hua ZhangYueqin Chen
Jun 14, 2014·PloS One·Shaoli DasJayprokas Chakrabarti
Nov 16, 2014·Nucleic Acids Research·Wei-Yun HuangHsien-Da Huang
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Feb 18, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Peifei LiJunming Guo
Apr 22, 2015·International Journal of Biological Sciences·Huan MengLiu Cao
Sep 13, 2015·Database : the Journal of Biological Databases and Curation·Zheng ZhaoXia Li
Dec 15, 2015·PLoS Genetics·Irene Hernando-HerraezTomas Marques-Bonet
Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Stamatia-Maria RaptiAndreas Scorilas
May 29, 2016·Molecular Cancer·Nenad BartonicekMarcel E Dinger
Dec 8, 2016·Nucleic Acids Research·Damian SzklarczykChristian von Mering

❮ Previous
Next ❯

Citations

Feb 29, 2020·Cancer Management and Research·Linlin LiKaichen Wang
Dec 4, 2019·Bioscience, Biotechnology, and Biochemistry·Xiaoming MaoHua Zhou
Apr 28, 2020·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Yinghui YuXin Liu
Jul 3, 2020·Cancer Cell International·Milad AshrafizadehSaeed Samarghandian
Sep 29, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Liao-Yuan WangGuang-Yu Ji
Jul 6, 2021·Journal of Healthcare Engineering·Shuoze Gao, Zhiping Wang
Aug 17, 2021·Cancer Biomarkers : Section a of Disease Markers·Danbi SeoWanyeon Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.